Clinical Trials Sponsored by BioEclipse Therapeutics
Total 6289 results
-
Enliven TherapeuticsRecruitingChronic Myeloid LeukemiaUnited States, Spain, France, Germany, Korea, Republic of, Australia
-
IntraGel TherapeuticsNot yet recruiting
-
Fate TherapeuticsRecruiting
-
Fulcrum TherapeuticsRecruitingSickle Cell Disease | Sickle Cell AnemiaUnited States
-
PTC TherapeuticsRecruitingPhenylketonuriaUnited States, Germany, Spain, Australia, Brazil, United Kingdom, Denmark, Mexico, Portugal, Turkey, Canada, Georgia, Italy, Netherlands, Japan
-
Karuna TherapeuticsRecruitingSchizophreniaUnited States, Bulgaria, Serbia
-
Visus TherapeuticsRecruiting
-
Tenaya TherapeuticsRecruitingNatural History Study in Pediatric Patients With MYBPC3 Mutation-associated Cardiomyopathy (MyCLIMB)CardiomyopathyUnited States, Canada, United Kingdom, Spain
-
Sage TherapeuticsRecruitingHuntington's DiseaseUnited States, Australia, Canada, United Kingdom
-
Protara TherapeuticsRecruitingNon-muscle Invasive Bladder CancerUnited States
-
Faeth TherapeuticsRecruitingMetastatic Pancreatic Adenocarcinoma | Locally Advanced Unresectable Pancreatic AdenocarcinomaUnited States
-
Aerovate TherapeuticsRecruitingPulmonary Arterial HypertensionUnited States, Belgium, Italy, Spain, Australia, Canada, China, Poland, Singapore, Argentina, United Kingdom, France, Israel, Latvia, Austria, Mexico, Puerto Rico, Sweden, South Africa, Netherlands, Chile, Germany, Greece, Portugal, Cze... and more
-
Allogene TherapeuticsRecruitingAdvanced/Metastatic Clear Cell Renal Cell CarcinomaUnited States
-
LIDDE TherapeuticsRecruitingHemorrhagic CystitisFrance
-
Harpoon TherapeuticsRecruitingNeuroendocrine Carcinoma | Small-Cell Lung CancerUnited States
-
Allogene TherapeuticsRecruitingRelapsed or Refractory Large B Cell Lymphoma, Relapsed or Refractory Chronic Lymphocytic Leukemia, Relapsed or Refractory Small Lymphocytic LymphomaUnited States, Spain, Canada, Australia, Italy
-
Tiburio TherapeuticsNot yet recruitingNon-Functional Pituitary Adenoma | Pituitary Tumor, Nonfunctioning
-
Corcept TherapeuticsRecruitingHypercortisolismUnited States, Austria, Bulgaria, Germany, Israel, Italy, Poland, Romania, Spain
-
Akcea TherapeuticsRecruitingHereditary Transthyretin Amyloidosis With PolyneuropthyUnited States, Canada
-
Amicus TherapeuticsRecruiting
-
Aspa TherapeuticsRecruiting
-
Effector TherapeuticsRecruitingSolid Tumor, AdultUnited States
-
Amicus TherapeuticsRecruitingPompe Disease (Late-onset)United States, Taiwan, Japan, Australia, Canada
-
Allogene TherapeuticsActive, not recruitingRelapsed/Refractory Large B Cell LymphomaUnited States, Belgium
-
MitoImmune TherapeuticsActive, not recruitingLymphoma | Multiple Myeloma | Oral Mucositis | Hematologic CancerKorea, Republic of
-
Harpoon TherapeuticsActive, not recruitingMultiple Myeloma | Multiple Myeloma in Relapse | Multiple Myeloma With Failed Remission | Multiple Myeloma of BoneUnited States, France, Spain
-
Intellia TherapeuticsEnrolling by invitationHereditary AngioedemaFrance, New Zealand, United Kingdom, Netherlands
-
PTC TherapeuticsActive, not recruitingFriedreich AtaxiaUnited States
-
Sage TherapeuticsCompletedHuntington DiseaseUnited States
-
PTC TherapeuticsActive, not recruitingAADC DeficiencyUnited States, Israel, Taiwan
-
OrphAI TherapeuticsCompletedAcute Myeloid Leukemia | OncologyUnited States
-
Sangamo TherapeuticsActive, not recruitingHemophilia B | Mucopolysaccharidosis I | Mucopolysaccharidosis IIUnited States
-
Corcept TherapeuticsActive, not recruitingAmyotrophic Lateral SclerosisUnited States, Belgium, Canada, France, Germany, Ireland, Netherlands, Poland, Spain, United Kingdom
-
Aprea TherapeuticsCompletedAcute Myeloid Leukemia or Myelodysplastic SyndromesUnited States
-
PTC TherapeuticsEnrolling by invitationDuchenne Muscular DystrophyUnited States, Canada
-
PTC TherapeuticsEnrolling by invitationFriedreich AtaxiaUnited States, Australia, Brazil, Canada, France, Germany, Italy, New Zealand, Spain
-
Geneos TherapeuticsActive, not recruitingHCCUnited States, New Zealand
-
Chelsea TherapeuticsCompletedAttention Deficit Hyperactivity DisorderUnited States
-
Sage TherapeuticsCompletedEssential TremorUnited States
-
Northern TherapeuticsTerminated
-
UNION therapeuticsCompletedSkin Diseases | PsoriasisUnited Kingdom, Poland, United States, Germany
-
Transcend TherapeuticsEnrolling by invitationPost Traumatic Stress DisorderUnited Kingdom
-
PTC TherapeuticsCompletedFriedreich AtaxiaUnited States, Australia, Brazil, Canada, France, Germany, Italy, New Zealand, Spain
-
Amicus TherapeuticsActive, not recruitingPompe Disease (Late-onset)United States, Germany, Taiwan, Belgium, Australia, Slovenia, Spain, Netherlands, Hungary, Japan, Austria, United Kingdom, France, Argentina, Canada, Sweden, Denmark, New Zealand, Greece, Korea, Republic of, Bosnia and Herzegovina, Ita... and more
-
Aligos TherapeuticsTerminatedChronic Hepatitis BNew Zealand, Bulgaria, Moldova, Republic of, Romania
-
PTC TherapeuticsCompletedLeiomyosarcomaUnited States
-
Fulcrum TherapeuticsTerminated
-
Nektar TherapeuticsCompletedCovid-19 | Coronavirus Disease 2019United States
-
Repare TherapeuticsActive, not recruitingAdvanced Solid TumorUnited States, Canada, Spain, United Kingdom